Kristine Glunde Selected Research

Phosphorylcholine (Phosphocholine)

10/2019	Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.
8/2017	Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.
1/2016	The Tumor Microenvironment Modulates Choline and Lipid Metabolism.
1/2016	Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion.
12/2015	Choline kinase-α protein and phosphatidylcholine but not phosphocholine are required for breast cancer cell survival.
6/2015	Choline metabolism-based molecular diagnosis of cancer: an update.
5/2014	Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.
1/2014	1H/31P polarization transfer at 9.4 Tesla for improved specificity of detecting phosphomonoesters and phosphodiesters in breast tumor models.
9/2012	Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
8/2012	Localized hypoxia results in spatially heterogeneous metabolic signatures in breast tumor models.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kristine Glunde Research Topics

Disease

55	Neoplasms (Cancer) 01/2022 - 11/2002
36	Breast Neoplasms (Breast Cancer) 05/2022 - 06/2004
11	Neoplasm Metastasis (Metastasis) 12/2021 - 07/2005
9	Hypoxia (Hypoxemia) 03/2016 - 01/2003
5	Carcinogenesis 10/2019 - 11/2011
4	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 01/2008
2	Glioma (Gliomas) 03/2016 - 01/2015
1	Inflammation (Inflammations) 06/2022
1	Neuroblastoma 12/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 03/2016
1	Circulating Neoplastic Cells 05/2015

Drug/Important Bio-Agent (IBA)

29	Choline (Choline Chloride)IBA 10/2019 - 11/2002
19	Phosphorylcholine (Phosphocholine)IBA 10/2019 - 10/2003
17	EnzymesIBA 01/2022 - 01/2003
16	Phospholipids (Phosphatides)FDA LinkGeneric 05/2022 - 10/2003
15	Choline KinaseIBA 01/2016 - 06/2004
8	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2003
8	Small Interfering RNA (siRNA)IBA 01/2018 - 12/2007
8	Proteins (Proteins, Gene)FDA Link 01/2017 - 04/2009
6	Phosphatidylcholines (Phosphatidylcholine)IBA 10/2019 - 06/2004
6	Pharmaceutical PreparationsIBA 08/2017 - 09/2006
5	LipidsIBA 01/2018 - 08/2012
5	tdTomatoIBA 01/2017 - 08/2012
5	CollagenIBA 10/2016 - 08/2010
4	Glucose (Dextrose)FDA LinkGeneric 06/2015 - 05/2009
3	phospholipase D1IBA 01/2016 - 09/2012
3	Messenger RNA (mRNA)IBA 12/2015 - 04/2009
3	Metalloproteases (Metalloproteinases)IBA 01/2015 - 06/2009
3	Red Fluorescent ProteinIBA 05/2013 - 01/2013
3	enhanced green fluorescent proteinIBA 08/2010 - 01/2008
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022 - 11/2002
2	Dinoprostone (PGE2)FDA Link 01/2022 - 10/2012
2	LuciferasesIBA 01/2021 - 11/2013
2	Ethanolamine (Colamine)IBA 01/2018 - 01/2016
2	phosphorylethanolamine (phosphoethanolamine)IBA 01/2018 - 01/2014
2	Phosphotransferases (Kinase)IBA 01/2018 - 10/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017 - 01/2016
2	Glutamic Acid (Glutamate)FDA Link 03/2016 - 01/2016
2	CreatineIBA 01/2016 - 01/2015
2	Inositol (Myoinositol)IBA 01/2016 - 01/2015
2	glycerophosphodiester phosphodiesteraseIBA 01/2016 - 09/2012
2	phosphatidylcholine-specific phospholipase CIBA 01/2016 - 03/2010
2	SodiumIBA 02/2013 - 11/2010
2	Estrogen ReceptorsIBA 09/2012 - 12/2007
2	Protein Isoforms (Isoforms)IBA 09/2012 - 07/2010
2	Glucosamine (Dona)IBA 04/2008 - 07/2005
2	Indomethacin (Indometacin)FDA LinkGeneric 09/2006 - 11/2002
1	Hormones (Hormone)IBA 01/2022
1	Contrast MediaIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 01/2022
1	Glycoproteins (Glycoprotein)IBA 12/2021
1	Polysaccharides (Glycans)IBA 12/2021
1	Epithelial Cell Adhesion MoleculeIBA 12/2021
1	Mannose (D-Mannose)IBA 12/2021
1	GoldIBA 07/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2020
1	CalciumIBA 01/2018
1	Durapatite (Hydroxylapatite)IBA 01/2018
1	OsteopontinIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Isoflurane FDA LinkGeneric 01/2018
1	N- (1- (4- (5- chloro- 2- oxo- 2,3- dihydro- 1H- benzo(d)imidazol- 1- yl)piperidin- 1- yl)propan- 2- yl)- 2- naphthamideIBA 08/2017
1	Proteoglycans (Proteoglycan)IBA 01/2017
1	N(1)-methylnicotinamideIBA 03/2016
1	pimonidazoleIBA 03/2016
1	Acetylcarnitine (Alcar)IBA 03/2016
1	compound 968IBA 03/2016
1	MRK 003IBA 03/2016
1	sapanisertibIBA 03/2016
1	LGK974IBA 03/2016
1	Temozolomide (Temodar)FDA LinkGeneric 03/2016
1	GlutaminaseIBA 03/2016
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2016
1	Phosphocreatine (Neoton)IBA 01/2016
1	ethanolamine kinaseIBA 01/2016
1	Phosphatidylethanolamine N-MethyltransferaseIBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 06/2015
1	CaspasesIBA 06/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2015
1	Cadherins (E-Cadherin)IBA 01/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2015
1	Matrix Metalloproteinases (MMPs)IBA 01/2015
1	IntegrinsIBA 01/2015
1	Phosphatidic Acids (Phosphatidic Acid)IBA 05/2014
1	glycerophosphoethanolamineIBA 01/2014
1	RNA (Ribonucleic Acid)IBA 11/2013
1	PalmitoylcarnitineIBA 02/2013
1	SphingomyelinsIBA 02/2013
1	PC 16IBA 02/2013
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 02/2013
1	ProdrugsIBA 09/2012
1	nile redIBA 08/2012

Therapy/Procedure

11	Therapeutics 06/2015 - 12/2005
7	Drug Therapy (Chemotherapy) 08/2017 - 12/2007
4	Precision Medicine 01/2022 - 02/2011
2	Intravenous Injections 05/2007 - 07/2005
1	Aftercare (After-Treatment) 08/2017
1	Lasers (Laser) 03/2016